opioids

Neuroscience discoveries, pharma investments, FOIA requests, and more led the news this week.

Vertex Pharmaceuticals’ drug, Journavx, blocks a sodium channel outside of the brain. Experts hope that this non-addictive pain drug may be the first of many.

Researchers studied an antidepressant that may help treat neuropathic pain.

A promising relationship between acetylcholine signaling and pain relief in mice could point the way to a non-opioid therapeutic.

New research aims to make antibody drug delivery as precise and efficient as the antibodies themselves.

Researchers harness pharmacogenomics to understand why individual patients react differently to opioids for pain relief. 

Researchers precisely engineered an antibody to better treat respiratory depression due to overdose from increasingly prevalent synthetic opioids.